Interleukin-1 and neuronal injury (original) (raw)

• Huising, M. O., Stet, R. J., Savelkoul, H. F. & Verburg-van Kemenade, B. M. The molecular evolution of the interleukin-1 family of cytokines; IL-18 in teleost fish. Dev. Comp. Immunol. 28, 395–413 (2004).
  Article CAS PubMed Google Scholar
• March, C. J. et al. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315, 641–647 (1985).
  Article CAS PubMed Google Scholar
• Thornberry, N. A. et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356, 768–774 (1992). A key paper that identified the enzyme that is responsible for cleavage of inactive pro-IL-1β to the mature biologically active protein.
  Article CAS PubMed Google Scholar
• Sims, J. E. et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241, 585–589 (1988).
  Article CAS PubMed Google Scholar
• Korherr, C., Hofmeister, R., Wesche, H. & Falk, W. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur. J. Immunol. 27, 262–267 (1997). An important paper that shows that recruitment of an accessory protein to the IL-1–IL-1R1 complex is essential for signal transduction to take place.
  Article CAS PubMed Google Scholar
• Subramaniam, S., Stansberg, C. & Cunningham, C. The interleukin 1 receptor family. Dev. Comp. Immunol. 28, 415–428 (2004).
  Article CAS PubMed Google Scholar
• Hannum, C. H. et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343, 336–340 (1990).
  Article CAS PubMed Google Scholar
• Malyak, M., Smith, M. F. Jr, Abel, A. A., Hance, K. R. & Arend, W. P. The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes. J. Immunol. 161, 2004–2010 (1998).
  CAS PubMed Google Scholar
• Dinarello, C. A. et al. Overview of interleukin-18: more than an interferon-γ inducing factor. J. Leukoc. Biol. 63, 658–664 (1998).
  Article CAS PubMed Google Scholar
• Dunne, A. & O'Neill, L. A. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE [online] 2003, RE3 (2003). A valuable updated review of the receptors of the IL-1-receptor and TLR family, and their signalling pathways.
  PubMed Google Scholar
• Sims, J. E. et al. A new nomenclature for IL-1-family genes. Trends Immunol. 22, 536–537 (2001).
  Article CAS PubMed Google Scholar
• Sims, J. E. IL-1 and IL-18 receptors, and their extended family. Curr. Opin. Immunol. 14, 117–122 (2002).
  Article CAS PubMed Google Scholar
• Vitkovic, L., Bockaert, J. & Jacque, C. 'Inflammatory' cytokines: neuromodulators in normal brain? J. Neurochem. 74, 457–471 (2000).
  Article CAS PubMed Google Scholar
• Watkins, L. R., Hansen, M. K., Nguyen, K. T., Lee, J. E. & Maier, S. F. Dynamic regulation of the proinflammatory cytokine, interleukin-1β: molecular biology for non-molecular biologists. Life Sci. 65, 449–481 (1999).
  Article CAS PubMed Google Scholar
• Hsu, H. Y. & Wen, M. H. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J. Biol. Chem. 277, 22131–22139 (2002).
  Article CAS PubMed Google Scholar
• Perregaux, D. G., Bhavsar, K., Contillo, L., Shi, J. & Gabel, C. A. Antimicrobial peptides initiate IL-1β posttranslational processing: a novel role beyond innate immunity. J. Immunol. 168, 3024–3032 (2002).
  Article CAS PubMed Google Scholar
• Eriksson, C., Tehranian, R., Iverfeldt, K., Winblad, B. & Schultzberg, M. Increased expression of mRNA encoding interleukin-1β and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration. J. Neurosci. Res. 60, 266–279 (2000).
  Article CAS PubMed Google Scholar
• Liu, L., Li, Y., Van Eldik, L. J., Griffin, W. S. & Barger, S. W. S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors. J. Neurochem. 92, 546–553 (2005).
  Article CAS PubMed Google Scholar
• Relton, J. K. et al. Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain. J. Exp. Med. 174, 305–310 (1991).
  Article CAS PubMed Google Scholar
• Kern, J. A., Warnock, L. J. & McCafferty, J. D. The 3′ untranslated region of IL-1β regulates protein production. J. Immunol. 158, 1187–1193 (1997).
  CAS PubMed Google Scholar
• Hazuda, D. J., Strickler, J., Kueppers, F., Simon, P. L. & Young, P. R. Processing of precursor interleukin 1β and inflammatory disease. J. Biol. Chem. 265, 6318–6322 (1990).
  CAS PubMed Google Scholar
• Perregaux, D. & Gabel, C. A. Interleukin-1β maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269, 15195–15203 (1994).
  CAS PubMed Google Scholar
• Le Feuvre, R. A., Brough, D., Iwakura, Y., Takeda, K. & Rothwell, N. J. Priming of macrophages with lipopolysaccharide potentiates P2X7-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine production. J. Biol. Chem. 277, 3210–3218 (2002).
  Article CAS PubMed Google Scholar
• Brough, D. et al. Ca2+ stores and Ca2+ entry differentially contribute to the release of IL-1β and IL-1α from murine macrophages. J. Immunol. 170, 3029–3036 (2003).
  Article CAS PubMed Google Scholar
• Andrei, C. et al. Phospholipases C and A2 control lysosome-mediated IL-1β secretion: implications for inflammatory processes. Proc. Natl Acad. Sci. USA 101, 9745–9750 (2004).
  Article CAS PubMed Google Scholar
• Walev, I., Reske, K., Palmer, M., Valeva, A. & Bhakdi, S. Potassium-inhibited processing of IL-1β in human monocytes. EMBO J. 14, 1607–1614 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Ferrari, D. et al. P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett. 447, 71–75 (1999).
  Article CAS PubMed Google Scholar
• Elssner, A., Duncan, M., Gavrilin, M. & Wewers, M. D. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release. J. Immunol. 172, 4987–4994 (2004).
  Article CAS PubMed Google Scholar
• Perregaux, D. G. et al. Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors. J. Pharmacol. Exp. Ther. 299, 187–197 (2001).
  CAS PubMed Google Scholar
• Laliberte, R. E. et al. Glutathione _S_-transferase ω 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1β posttranslational processing. J. Biol. Chem. 278, 16567–16578 (2003).
  Article CAS PubMed Google Scholar
• Li, Y. J. et al. Glutathione _S_-transferase ω-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum. Mol. Genet. 12, 3259–3267 (2003).
  Article CAS PubMed Google Scholar
• Schneider, H. et al. A neuromodulatory role of interleukin-1β in the hippocampus. Proc. Natl Acad. Sci. USA 95, 7778–7783 (1998).
  Article CAS PubMed Google Scholar
• Kelley, K. W. et al. Cytokine-induced sickness behavior. Brain Behav. Immun. 17, S112–S118 (2003).
  Article CAS PubMed Google Scholar
• Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F. & Besedovsky, H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238, 524–526 (1987).
  Article CAS PubMed Google Scholar
• Boutin, H., Kimber, I., Rothwell, N. J. & Pinteaux, E. The expanding interleukin-1 family and its receptors: do alternative IL-1 receptor/signaling pathways exist in the brain? Mol. Neurobiol. 27, 239–248 (2003).
  Article CAS PubMed Google Scholar
• Debets, R. et al. Two novel IL-1 family members, IL-1δ and IL-1ε, function as an antagonist and agonist of NF-κB activation through the orphan IL- 1 receptor-related protein 2. J. Immunol. 167, 1440–1446 (2001).
  Article CAS PubMed Google Scholar
• Lovenberg, T. W. et al. Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL1R-rp2). J. Neuroimmunol. 70, 113–122 (1996).
  Article CAS PubMed Google Scholar
• Berglof, E. et al. IL-1Rrp2 expression and IL-1F9 (IL-1H1) actions in brain cells. J. Neuroimmunol. 139, 36–43 (2003).
  Article CAS PubMed Google Scholar
• Wang, P. et al. The interleukin-1-related cytokine IL-1F8 is expressed in glial cells, but fails to induce IL-1β signalling responses. Cytokine 29, 245–250 (2005).
  PubMed Google Scholar
• Ching, S., He, L., Lai, W. & Quan, N. IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system. Brain Behav. Immun. 19, 127–137 (2005).
  Article CAS PubMed Google Scholar
• Loddick, S. A. et al. Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochem. Biophys. Res. Commun. 234, 211–215 (1997).
  Article CAS PubMed Google Scholar
• Carvey, P. M. et al. Intra-parenchymal injection of tumor necrosis factor-α and interleukin 1-β produces dopamine neuron loss in the rat. J. Neural Transm. 112, 601–612 (2005). One of the few papers to show direct neurotoxic effects of IL-1.
  Article CAS PubMed Google Scholar
• Lawrence, C. B., Allan, S. M. & Rothwell, N. J. Interleukin-1β and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur. J. Neurosci. 10, 1188–1195 (1998).
  Article CAS PubMed Google Scholar
• Chao, C. C., Hu, S., Ehrlich, L. & Peterson, P. K. Interleukin-1 and tumor necrosis factor-α synergistically mediate neurotoxicity: involvement of nitric oxide and of _N_-methyl-D-aspartate receptors. Brain. Behav. Immun. 9, 355–365 (1995).
  Article CAS PubMed Google Scholar
• Hu, S., Peterson, P. K. & Chao, C. C. Cytokine-mediated neuronal apoptosis. Neurochem. Int. 30, 427–431 (1997).
  Article CAS PubMed Google Scholar
• Downen, M., Amaral, T. D., Hua, L. L., Zhao, M. L. & Lee, S. C. Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-α. Glia 28, 114–127 (1999).
  Article CAS PubMed Google Scholar
• Yamasaki, Y. et al. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26, 676–681 (1995). The first study to show that administration of exogenous IL-1 can exacerbate experimental neuronal injury.
  Article CAS PubMed Google Scholar
• Relton, J. K. & Rothwell, N. J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29, 243–246 (1992). The first paper to report the neuroprotective effects of IL-1RA in neuronal injury.
  Article CAS PubMed Google Scholar
• Rothwell, N. Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav. Immun. 17, 152–157 (2003).
  Article PubMed Google Scholar
• Vezzani, A. et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl Acad. Sci. USA 97, 11534–11539 (2000).
  Article CAS PubMed Google Scholar
• Lin, M. T., Kao, T. Y., Jin, Y. T. & Chen, C. F. Interleukin-1 receptor antagonist attenuates the heat stroke-induced neuronal damage by reducing the cerebral ischemia in rats. Brain Res. Bull. 37, 595–598 (1995).
  Article CAS PubMed Google Scholar
• Loscher, C. E., Mills, K. H. & Lynch, M. A. Interleukin-1 receptor antagonist exerts agonist activity in the hippocampus independent of the interleukin-1 type I receptor. J. Neuroimmunol. 137, 117–124 (2003).
  Article CAS PubMed Google Scholar
• Hara, H. et al. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl Acad. Sci. USA 94, 2007–2012 (1997). The first paper to show that inhibition of the enzyme responsible for production of the mature, active IL-1β protein provides neuroprotection.
  Article CAS PubMed Google Scholar
• Boutin, H. et al. Role of IL-1α and IL-1β in ischemic brain damage. J. Neurosci. 21, 5528–5534 (2001).
  Article CAS PubMed Google Scholar
• Boutin, H. & Rothwell, N. J. in Pharmacology of Cerebral Ischaemia (eds Krieglstein, J. & Klumpp, S.) 183–190 (Medpharm, Stuttgart, 2002).
  Google Scholar
• Strijbos, P. J. & Rothwell, N. J. Interleukin-1β attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neurosci. 15, 3468–3474 (1995).
  Article CAS PubMed Google Scholar
• Carlson, N. G. et al. Inflammatory cytokines IL-1α, IL-1β, IL-6, and TNF-α impart neuroprotection to an excitotoxin through distinct pathways. J. Immunol. 163, 3963–3968 (1999).
  CAS PubMed Google Scholar
• Viviani, B. et al. Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 23, 8692–8700 (2003).
  Article CAS PubMed Google Scholar
• Pringle, A. K., Niyadurupola, N., Johns, P., Anthony, D. C. & Iannotti, F. Interleukin-1β exacerbates hypoxia-induced neuronal damage, but attenuates toxicity produced by simulated ischaemia and excitotoxicity in rat organotypic hippocampal slice cultures. Neurosci. Lett. 305, 29–32 (2001).
  Article CAS PubMed Google Scholar
• Busto, R. et al. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J. Cereb. Blood Flow Metab. 7, 729–738 (1987).
  Article CAS PubMed Google Scholar
• Azzimondi, G. et al. Fever in acute stroke worsens prognosis. A prospective study. Stroke 26, 2040–2043 (1995).
  Article CAS PubMed Google Scholar
• Monroy, M., Kuluz, J. W., He, D., Dietrich, W. D. & Schleien, C. L. Role of nitric oxide in the cerebrovascular and thermoregulatory response to interleukin-1β. Am. J. Physiol. Heart Circ. Physiol. 280, H1448–H1453 (2001).
  Article CAS PubMed Google Scholar
• Maher, C. O., Anderson, R. E., Martin, H. S., McClelland, R. L. & Meyer, F. B. Interleukin-1β and adverse effects on cerebral blood flow during long-term global hypoperfusion. J. Neurosurg. 99, 907–912 (2003).
  Article CAS PubMed Google Scholar
• Fassbender, K., Schmidt, R., Mossner, R., Daffertshofer, M. & Hennerici, M. Pattern of activation of the hypothalamic–pituitary–adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome. Stroke 25, 1105–1108 (1994).
  Article CAS PubMed Google Scholar
• Srinivasan, D., Yen, J. H., Joseph, D. J. & Friedman, W. Cell type-specific interleukin-1β signaling in the CNS. J. Neurosci. 24, 6482–6488 (2004).
  Article CAS PubMed Google Scholar
• Touzani, O. et al. Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor. J. Neurosci. 22, 38–43 (2002). The first report that IL-1β has effects in the CNS that are not mediated through binding IL-1R1, the classical IL-1 signalling receptor.
  Article CAS PubMed Google Scholar
• Basu, A. et al. Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic/ischemic injury. J. Cereb. Blood Flow Metab. 25, 17–29 (2005).
  Article CAS PubMed Google Scholar
• Parker, L. C., Luheshi, G. N., Rothwell, N. J. & Pinteaux, E. IL-1β signalling in glial cells in wildtype and IL-1RI deficient mice. Br. J. Pharmacol. 136, 312–320 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Allan, S. M. & Rothwell, N. J. Cytokines and acute neurodegeneration. Nature Rev. Neurosci. 2, 734–744 (2001).
  Article CAS Google Scholar
• Vezzani, A. et al. Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 19, 5054–5065 (1999).
  Article CAS PubMed Google Scholar
• Chen, Y. & Swanson, R. A. Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 23, 137–149 (2003).
  Article PubMed Google Scholar
• John, G. R., Lee, S. C., Song, X., Rivieccio, M. & Brosnan, C. F. IL-1-regulated responses in astrocytes: relevance to injury and recovery. Glia 49, 161–176 (2005).
  Article PubMed Google Scholar
• Basu, A., Krady, J. K. & Levison, S. W. Interleukin-1: a master regulator of neuroinflammation. J. Neurosci. Res. 78, 151–156 (2004).
  Article CAS PubMed Google Scholar
• Aloisi, F. Immune function of microglia. Glia 36, 165–179 (2001).
  Article CAS PubMed Google Scholar
• Pinteaux, E., Parker, L. C., Rothwell, N. J. & Luheshi, G. N. Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J. Neurochem. 83, 754–763 (2002).
  Article CAS PubMed Google Scholar
• Vela, J. M., Molina-Holgado, E., Arevalo-Martin, A., Almazan, G. & Guaza, C. Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol. Cell. Neurosci. 20, 489–502 (2002).
  Article CAS PubMed Google Scholar
• Mason, J. L., Suzuki, K., Chaplin, D. D. & Matsushima, G. K. Interleukin-1β promotes repair of the CNS. J. Neurosci. 21, 7046–7052 (2001).
  Article CAS PubMed Google Scholar
• Konsman, J. P., Vigues, S., Mackerlova, L., Bristow, A. & Blomqvist, A. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J. Comp. Neurol. 472, 113–129 (2004).
  Article PubMed Google Scholar
• Proescholdt, M. G. et al. Intracerebroventricular but not intravenous interleukin-1β induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation. Neuroscience 112, 731–749 (2002).
  Article CAS PubMed Google Scholar
• Bernardes-Silva, M., Anthony, D. C., Issekutz, A. C. & Perry, V. H. Recruitment of neutrophils across the blood–brain barrier: the role of E- and P-selectins. J. Cereb. Blood Flow Metab. 21, 1115–1124 (2001).
  Article CAS PubMed Google Scholar
• Anthony, D. et al. CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood–brain barrier breakdown. Curr. Biol. 8, 923–926 (1998).
  Article CAS PubMed Google Scholar
• Mazzotta, G. et al. Different cytokine levels in thrombolysis patients as predictors for clinical outcome. Eur. J. Neurol. 11, 377–381 (2004).
  Article CAS PubMed Google Scholar
• Fassbender, K. et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J. Neurol. Sci. 122, 135–139 (1994).
  Article CAS PubMed Google Scholar
• Tarkowski, E. et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26, 1393–1398 (1995). One of the earliest studies to show that concentrations of IL-1β are increased in patients who have suffered a clinical stroke.
  Article CAS PubMed Google Scholar
• Kostulas, N., Pelidou, S. H., Kivisakk, P., Kostulas, V. & Link, H. Increased IL-1β, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 30, 2174–2179 (1999).
  Article CAS PubMed Google Scholar
• Beamer, N. B., Coull, B. M., Clark, W. M., Hazel, J. S. & Silberger, J. R. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann. Neurol. 37, 800–805 (1995).
  Article CAS PubMed Google Scholar
• Fassbender, K. et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J. Neurol. Neurosurg. Psychiatry 70, 534–537 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Mathiesen, T., Edner, G., Ulfarsson, E. & Andersson, B. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-α following subarachnoid hemorrhage. J. Neurosurg. 87, 215–220 (1997).
  Article CAS PubMed Google Scholar
• Gladstone, D. J., Black, S. E. & Hakim, A. M. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33, 2123–2136 (2002).
  Article PubMed Google Scholar
• Bresnihan, B. The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Semin. Arthritis Rheum. 30, 17–20 (2001).
  Article CAS PubMed Google Scholar
• Fisher, C. J. Jr. et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. The IL-1RA Sepsis Syndrome Study Group. Crit. Care Med. 22, 12–21 (1994).
  Article PubMed Google Scholar
• Opal, S. M. et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a Phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit. Care Med. 25, 1115–1124 (1997).
  Article CAS PubMed Google Scholar
• Stroke Therapy Academic Industry Roundtable II (STAIR-II). Recommendations for clinical trial evaluation of acute stroke therapies. Stroke 32, 1598–1606 (2001).
• Emsley, H. C. et al. A randomised Phase II study of interleukin-1 receptor antagonist in acute stroke patients. J. Neurol. Neurosurg. Psychiatry (in the press). The findings of the first clinical trial of IL-1RA for the treatment of patients who have suffered an acute stroke.
• Springborg, J. B., Frederiksen, H. J., Eskesen, V. & Olsen, N. V. Trends in monitoring patients with aneurysmal subarachnoid haemorrhage. Br. J. Anaesth. 94, 259–270 (2005).
  Article CAS PubMed Google Scholar
• Campbell, S. J. et al. CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J. 17, 1168–1170 (2003).
  Article CAS PubMed Google Scholar
• Obal, F. Jr. et al. Interleukin 1α and an interleukin 1β fragment are somnogenic. Am. J. Physiol. 259, R439–R446 (1990).
  Article CAS PubMed Google Scholar
• Fang, J., Wang, Y. & Krueger, J. M. Effects of interleukin-1β on sleep are mediated by the type I receptor. Am. J. Physiol. 274, R655–R660 (1998).
  CAS PubMed Google Scholar
• Avital, A. et al. Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 13, 826–834 (2003).
  Article CAS PubMed Google Scholar
• Vamvakopoulos, J., Green, C. & Metcalfe, S. Genetic control of IL-1β bioactivity through differential regulation of the IL-1 receptor antagonist. Eur. J. Immunol. 32, 2988–2996 (2002).
  Article CAS PubMed Google Scholar
• Francis, S. E. et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99, 861–866 (1999).
  Article CAS PubMed Google Scholar
• Worrall, B. B. et al. Interleukin-1 receptor antagonist gene polymorphisms in carotid atherosclerosis. Stroke 34, 790–793 (2003).
  Article CAS PubMed Google Scholar
• Dominici, R. et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1α. Immunogenetics 54, 82–86 (2002).
  Article CAS PubMed Google Scholar
• Um, J. Y. et al. Association of interleukin-1α gene polymorphism with cerebral infarction. Brain Res. Mol. Brain Res. 115, 50–54 (2003).
  Article CAS PubMed Google Scholar
• Seripa, D. et al. Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. Cerebrovasc. Dis. 15, 276–281 (2003).
  Article CAS PubMed Google Scholar
• Lee, B. C. et al. Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-α genes, but not the interleukin-1β gene. Neurosci. Lett. 357, 33–36 (2004).
  Article CAS PubMed Google Scholar
• Iacoviello, L. et al. Polymorphisms of the interleukin-1β gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler. Thromb. Vasc. Biol. 25, 222–227 (2005).
  Article CAS PubMed Google Scholar
• Cullup, H., Middleton, P. G., Duggan, G., Conn, J. S. & Dickinson, A. M. Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individuals. Clin. Exp. Immunol. 137, 351–358 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Ooboshi, H., Ibayashi, S., Takada, J., Kumai, Y. & Iida, M. Brain ischemia as a potential target of gene therapy. Exp. Gerontol. 38, 183–187 (2003).
  Article CAS PubMed Google Scholar
• Spera, P. A., Ellison, J. A., Feuerstein, G. Z. & Barone, F. C. IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 251, 189–192 (1998).
  Article CAS PubMed Google Scholar
• Molina-Holgado, F. et al. Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. J. Neurosci. 23, 6470–6474 (2003).
  Article CAS PubMed Google Scholar